Biobeat widens lead over Apple, Fitbit with FDA nod to add more vital sign monitoring to smartwatch | Fierce Biotech
Thai Heart - FDA approved Biobeat's “smartwatch and patch to monitor blood pressure and other vital signs.” The Israel-based company said this is the first FDA approval of a blood pressure monitor
research2guidance - How the first FDA-cleared cuffless blood pressure solution is paving the way to new remote monitoring technologies? – Interview with Dr. Eisenkraft, Chief Medical Officer of Biobeat